Study of NGR-hTNF Administered at High Doses in Patient With Advanced or Metastatic Solid Tumour
Clinical trial NCT00878111 · COMPLETED
Trial details
- NCT number
- NCT00878111
- Sponsor
- AGC Biologics S.p.A.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2009-04-01
- Primary completion
- 2017-02-01
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.